MyFinsight
Home
Blog
About
Back
Income Statement
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL)
source: myfinsight.com
Net loss
-$42,286,000
(-57.35%↓ Y/Y)
Net loss before
income taxes
-$42,148,000
(-56.84%↓ Y/Y)
Income tax expense
$138,000
Investment and other
income, net
$2,243,000
(-75.58%↓ Y/Y)
Loss from operations
-$44,391,000
(-23.11%↓ Y/Y)
Total operating
expenses
$44,391,000
(23.11%↑ Y/Y)
Research and development
$35,163,000
(27.36%↑ Y/Y)
General and
administrative
$9,228,000
(9.23%↑ Y/Y)
Back